NCT00320424View on ClinicalTrials.gov

Hip Fracture Study of GSK576428 (Fondaparinux Sodium)

PHASE3CompletedINTERVENTIONAL

Enrollment

48

Participants

Timeline

Start Date

February 16, 2006

Primary Completion Date

October 26, 2006

Study Completion Date

October 26, 2006

Conditions

Thromboembolism

Interventions

DRUG

Fondaparinux

Trial Locations (1)

Unknown

GSK Investigational Site

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY